The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016

Detalhes bibliográficos
Autor(a) principal: Braz, Paula
Data de Publicação: 2018
Outros Autores: Machado, Ausenda, Matias Dias, Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.18/5782
Resumo: The term prenatal diagnosis comprises a variety of techniques aimed to determine the health and condition of the embryo or foetus. Its main goal is to identify at an early stage of the pregnancy, if possible, malformations or other conditions that could increase the risk of a negative outcome in the pregnancy. The aim of this study was to assess the impact of prenatal diagnosis in Portugal in pregnancies with congenital anomalies. A cross sectional study was implemented using data for the years 1997 to 2016 from the Portuguese registry of congenital anomalies (RENAC), a population-based registry that follows EUROCAT guidelines. Analysis was restricted to malformations that are potentially detectable by prenatal diagnosis. The effect of prenatal diagnosis on outcome (death vs live birth) was estimated using a regression model. Main results indicate that prenatal diagnosis was performed in 56.1% (n = 7605) of all registered cases. At least one malformation was detected for the first time through ultrasound (47.4%), invasive tests (5.6%) and other tests (2.2%). When analysed severe CA, 54.2% was detectible by prenatal ultrasound distributed as follows: 17.4% were diagnosed before 14 weeks of gestation, 47.6% between 14 and 23 weeks and 35.0% with 24 or more weeks of gestation. TOPFA was the option for 21.3% of these CA. Over the 20 years of analysis, there was a statistically significant increase trend in the detection rate of congenital anomalies through prenatal diagnosis compared to detection at birth or after birth (p < 0.001). After adjusting for confounding (year, maternal age, presence of more than one malformation), prenatal diagnosis was associated with more severe outcomes (TOPFA, 40.3%; Death 3.5%) and increased the risk of the pregnancy ending in foetal death (OR = 2.56; 95%CI = 2.06-3.18). These results are in accordance that more severe anomalies are more easily detected prenatally. Considering the results, it is important to raise awareness about the importance of pregnancy planning and preventing the risk factors more associated with CA. More information about prognosis for children with congenital malformations is important for parents and health professionals after prenatal detection.
id RCAP_bcbea660955a10711decd70fb27b3334
oai_identifier_str oai:repositorio.insa.pt:10400.18/5782
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016Congenital AnomaliesHeath ImpactPrenatal DagnosisRENACDiagnóstico PrenatalCuidados de SaúdeAnomalias CongenitasPortugalThe term prenatal diagnosis comprises a variety of techniques aimed to determine the health and condition of the embryo or foetus. Its main goal is to identify at an early stage of the pregnancy, if possible, malformations or other conditions that could increase the risk of a negative outcome in the pregnancy. The aim of this study was to assess the impact of prenatal diagnosis in Portugal in pregnancies with congenital anomalies. A cross sectional study was implemented using data for the years 1997 to 2016 from the Portuguese registry of congenital anomalies (RENAC), a population-based registry that follows EUROCAT guidelines. Analysis was restricted to malformations that are potentially detectable by prenatal diagnosis. The effect of prenatal diagnosis on outcome (death vs live birth) was estimated using a regression model. Main results indicate that prenatal diagnosis was performed in 56.1% (n = 7605) of all registered cases. At least one malformation was detected for the first time through ultrasound (47.4%), invasive tests (5.6%) and other tests (2.2%). When analysed severe CA, 54.2% was detectible by prenatal ultrasound distributed as follows: 17.4% were diagnosed before 14 weeks of gestation, 47.6% between 14 and 23 weeks and 35.0% with 24 or more weeks of gestation. TOPFA was the option for 21.3% of these CA. Over the 20 years of analysis, there was a statistically significant increase trend in the detection rate of congenital anomalies through prenatal diagnosis compared to detection at birth or after birth (p < 0.001). After adjusting for confounding (year, maternal age, presence of more than one malformation), prenatal diagnosis was associated with more severe outcomes (TOPFA, 40.3%; Death 3.5%) and increased the risk of the pregnancy ending in foetal death (OR = 2.56; 95%CI = 2.06-3.18). These results are in accordance that more severe anomalies are more easily detected prenatally. Considering the results, it is important to raise awareness about the importance of pregnancy planning and preventing the risk factors more associated with CA. More information about prognosis for children with congenital malformations is important for parents and health professionals after prenatal detection.ElsevierRepositório Científico do Instituto Nacional de SaúdeBraz, PaulaMachado, AusendaMatias Dias, Carlos2020-01-01T01:30:10Z2018-092018-09-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/5782engEur J Med Genet. 2018 Sep;61(9):508-512. doi: 10.1016/j.ejmg.2018.06.006. Epub 2018 Jun 141769-7212https://doi.org/10.1016/j.ejmg.2018.06.006info:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:40:58Zoai:repositorio.insa.pt:10400.18/5782Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:40:20.086257Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
title The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
spellingShingle The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
Braz, Paula
Congenital Anomalies
Heath Impact
Prenatal Dagnosis
RENAC
Diagnóstico Prenatal
Cuidados de Saúde
Anomalias Congenitas
Portugal
title_short The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
title_full The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
title_fullStr The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
title_full_unstemmed The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
title_sort The impact of prenatal diagnosis on congenital anomaly outcomes: Data from 1997 to 2016
author Braz, Paula
author_facet Braz, Paula
Machado, Ausenda
Matias Dias, Carlos
author_role author
author2 Machado, Ausenda
Matias Dias, Carlos
author2_role author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Braz, Paula
Machado, Ausenda
Matias Dias, Carlos
dc.subject.por.fl_str_mv Congenital Anomalies
Heath Impact
Prenatal Dagnosis
RENAC
Diagnóstico Prenatal
Cuidados de Saúde
Anomalias Congenitas
Portugal
topic Congenital Anomalies
Heath Impact
Prenatal Dagnosis
RENAC
Diagnóstico Prenatal
Cuidados de Saúde
Anomalias Congenitas
Portugal
description The term prenatal diagnosis comprises a variety of techniques aimed to determine the health and condition of the embryo or foetus. Its main goal is to identify at an early stage of the pregnancy, if possible, malformations or other conditions that could increase the risk of a negative outcome in the pregnancy. The aim of this study was to assess the impact of prenatal diagnosis in Portugal in pregnancies with congenital anomalies. A cross sectional study was implemented using data for the years 1997 to 2016 from the Portuguese registry of congenital anomalies (RENAC), a population-based registry that follows EUROCAT guidelines. Analysis was restricted to malformations that are potentially detectable by prenatal diagnosis. The effect of prenatal diagnosis on outcome (death vs live birth) was estimated using a regression model. Main results indicate that prenatal diagnosis was performed in 56.1% (n = 7605) of all registered cases. At least one malformation was detected for the first time through ultrasound (47.4%), invasive tests (5.6%) and other tests (2.2%). When analysed severe CA, 54.2% was detectible by prenatal ultrasound distributed as follows: 17.4% were diagnosed before 14 weeks of gestation, 47.6% between 14 and 23 weeks and 35.0% with 24 or more weeks of gestation. TOPFA was the option for 21.3% of these CA. Over the 20 years of analysis, there was a statistically significant increase trend in the detection rate of congenital anomalies through prenatal diagnosis compared to detection at birth or after birth (p < 0.001). After adjusting for confounding (year, maternal age, presence of more than one malformation), prenatal diagnosis was associated with more severe outcomes (TOPFA, 40.3%; Death 3.5%) and increased the risk of the pregnancy ending in foetal death (OR = 2.56; 95%CI = 2.06-3.18). These results are in accordance that more severe anomalies are more easily detected prenatally. Considering the results, it is important to raise awareness about the importance of pregnancy planning and preventing the risk factors more associated with CA. More information about prognosis for children with congenital malformations is important for parents and health professionals after prenatal detection.
publishDate 2018
dc.date.none.fl_str_mv 2018-09
2018-09-01T00:00:00Z
2020-01-01T01:30:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/5782
url http://hdl.handle.net/10400.18/5782
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur J Med Genet. 2018 Sep;61(9):508-512. doi: 10.1016/j.ejmg.2018.06.006. Epub 2018 Jun 14
1769-7212
https://doi.org/10.1016/j.ejmg.2018.06.006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132144512008192